Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Tariq Zuheir Kewan, MD, Shafia Rahman, MBBS, Fahrettin Covut, MD, Ramsha Ahmed, MD, Seba Hasan, Yihong Zhou, MD, Alok A Khorana, MD

Blood (2019) 134 (Supplement_1): 3683.

https://doi.org/10.1182/blood-2019-131758

Published: 2019

Journal Articles

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation

Brian J. Carney, MD, Erik J. Uhlmann, MD, Maneka Puligandla, MS, Charlene Mantia, MD, Griffin M. Weber, MD PhD, Donna S Neuberg, ScD, Jeffrey I. Zwicker, MD

Blood (2019) 134 (Supplement_1): 2438.

https://doi.org/10.1182/blood-2019-126027

Published: 2019

Journal Articles

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Andrew Dunbar, MD, Kelly Bolton, MD PhD, Sean M. Devlin, PhD, Francisco Sanchez-Vega, PhD, Jianjiong Gao, PhD, Jodi V. Mones, MD, Jonathan M. Wills, BA, Daniel Kelly, MS, Mirko Farina, MD, Sirish Kishore, MD, Krishna Juluru, MD, Neil Iyengar, MD, David M. Hyman, MD, Ahmet Zehir, PhD, Wungki Park, MD, Alok A Khorana, MD, Gerald A. Soff, MD, Simon Mantha, MDMPH

Blood (2019) 134 (Supplement_1): 633.

https://doi.org/10.1182/blood-2019-124242

Published: 2019

Journal Articles

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

Brian J. Carney, MD, Erik J. Uhlmann, MD, Maneka Puligandla, MS, Charlene Mantia, MD, Griffin M. Weber, MD PhD, Donna S Neuberg, ScD, Jeffrey I. Zwicker, MD

Blood (2018) 132 (Supplement 1): 2521.

https://doi.org/10.1182/blood-2018-99-115666

Published: 2018

Journal Articles

Platelet (hem)ITAM Signaling Mediated Cancer-Associated Venous Thrombosis

Xia Wang, MD, Jingchang Wu, PhD, Haidi Gu, MD, Jun Qian, PhD, Changgeng Ruan, MD PhD, Yiming Zhao, PhD

Blood (2018) 132 (Supplement 1): 2509.

https://doi.org/10.1182/blood-2018-99-116220

Published: 2018

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

Outcomes Associated with Therapeutic Anticoagulation in Patients with Brain Metastasis

Shafia Rahman, MD, Fahrettin Covut, MD, Yihong Zhou, MD, Shab E Gul Rahim, MD, Sudha Amarnath, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1242.

https://doi.org/10.1182/blood-2018-99-119686

Published: 2018

Journal Articles

Clinical Relevance of Intracranial Hemorrhage Volume in Primary and Metastatic Brain Tumors

Mohana Roy, MD, Charlene Mantia, MD, Erik J Uhlmann, MD, Maneka Puligandla, MS, Griffin Weber, MD PhD, Donna S. Neuberg, ScD, Jeffrey I Zwicker, MD

Blood (2017) 130 (Supplement 1): 2388.

https://doi.org/10.1182/blood.V130.Suppl_1.2388.2388

Published: 2017

Journal Articles

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Julia Riedl, Matthias Preusser, Pegah Mir Seyed Nazari, Florian Posch, Simon Panzer, Christine Marosi, Peter Birner, Johannes Thaler, Christine Brostjan, Daniela Lötsch, Walter Berger, Johannes A. Hainfellner, Ingrid Pabinger, Cihan Ay

Blood (2017) 129 (13): 1831–1839.

https://doi.org/10.1182/blood-2016-06-720714

Published: 2017

Includes: Supplemental data

Journal Articles

Intracranial Hemorrhage in Patients with Primary Brain Tumors Treated with Therapeutic Enoxaparin: A Matched Cohort Study

Charlene Mantia, MD, Erik Uhlmann, MD, Maneka Puligandla, MS, Donna S. Neuberg, ScD, Griffin M. Weber, MD PhD, Jeffrey I. Zwicker, MD

Blood (2016) 128 (22): 142.

https://doi.org/10.1182/blood.V128.22.142.142

Published: 2016

Journal Articles

Somatic Mutations Detected in Plasma Cell-Free DNA By Targeted Sequencing: Assessment of Liquid Biopsy in Primary Central Nervous System Lymphoma

Maxime Fontanilles, Florent Marguet, Élodie Bohers, Pierre-Julien Viailly, Philippe Bertrand, PhD, Sydney Dubois, Sylvain Mareschal, Vincent Camus, Elena-Liana Veresezan, Philippe Ruminy, PhD, Hervé Tilly, MD PhD, Annie Laquerriere, Jean-Michel Picquenot, PhD, Fabrice Jardin, MD PhD

Blood (2015) 126 (23): 332.

https://doi.org/10.1182/blood.V126.23.332.332

Published: 2015

Journal Articles

Outcomes of Low-Molecular-Weight Heparintreatment for Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors

Chatree Chai-Adisaksopha, MD, Said Y. ALKindi, MD ARCPath, Matthew Cheah, Alfonso Iorio, MD PhD, Mark A. Crowther, MD MSc, FRCPC, Lori Ann Linkins, MD MSc, FRCPC

Blood (2015) 126 (23): 428.

https://doi.org/10.1182/blood.V126.23.428.428

Published: 2015

Journal Articles

Risk of Intracranial Hemorrhage Associated with Enoxaparin Administration in Patients with Brain Metastasis

Jessica Donato, MD, Federico Campigotto, MS, Erika Coletti, BSN, Donna Neuberg, ScD, Griffin Weber, MD PhD, Jeffrey I. Zwicker, MD

Blood (2014) 124 (21): 348.

https://doi.org/10.1182/blood.V124.21.348.348

Published: 2014

Journal Articles

Treatment Of Primary Central Nervous System Lymphoma In The HIV-Positive Patient: Should We Be Doing More?

Jeremy Clifton Jones, MD, Harris V. Naina, MD, Yu-Min P Shen, MD

Blood (2013) 122 (21): 4362.

https://doi.org/10.1182/blood.V122.21.4362.4362

Published: 2013

NARROW

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

Platelet (hem)ITAM Signaling Mediated Cancer-Associated Venous Thrombosis

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Outcomes Associated with Therapeutic Anticoagulation in Patients with Brain Metastasis

Clinical Relevance of Intracranial Hemorrhage Volume in Primary and Metastatic Brain Tumors

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Intracranial Hemorrhage in Patients with Primary Brain Tumors Treated with Therapeutic Enoxaparin: A Matched Cohort Study

Somatic Mutations Detected in Plasma Cell-Free DNA By Targeted Sequencing: Assessment of Liquid Biopsy in Primary Central Nervous System Lymphoma

Outcomes of Low-Molecular-Weight Heparintreatment for Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors

Risk of Intracranial Hemorrhage Associated with Enoxaparin Administration in Patients with Brain Metastasis

Treatment Of Primary Central Nervous System Lymphoma In The HIV-Positive Patient: Should We Be Doing More?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only